<?xml version="1.0" encoding="UTF-8"?>
<ref id="B60">
 <label>60.</label>
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>Vaxart</collab>
  </person-group>
  <article-title>Press Release Details</article-title>. 
  <source>Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial</source>. Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://investors.vaxart.com/news-releases/news-release-details/vaxart-doses-first-patient-randomized-cohort-bivalent-norovirus" xmlns:xlink="http://www.w3.org/1999/xlink">https://investors.vaxart.com/news-releases/news-release-details/vaxart-doses-first-patient-randomized-cohort-bivalent-norovirus</ext-link>. (accessed August 31, 2019).
 </mixed-citation>
</ref>
